Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
J Diabetes ; 15(8): 665-673, 2023 Aug.
Article in English | MEDLINE | ID: mdl-37438984

ABSTRACT

The rising prevalence of metabolic disorders such as obesity and type 2 diabetes mellitus (T2DM) poses a major challenge to global health. Existing therapeutic approaches have limitations, and there is a need for new, safe, and less invasive treatments. Interventional metabolic therapy is a new addition to the treatment arsenal for metabolic disorders. This review focuses on two interventional techniques: bariatric arterial embolization (BAE) and endovascular denervation (EDN). BAE involves embolizing specific arteries feeding ghrelin-producing cells to suppress appetite and promote weight loss. EDN targets nerves that regulate metabolic organs to improve glycemic control in T2DM patients. We describe the current state of these techniques, their mechanisms of action, and the available safety and effectiveness data. We also propose a new territory called "Interventional Metabology" to encompass these and other interventional approaches to treating metabolic disorders.


Subject(s)
Bariatric Surgery , Bariatrics , Diabetes Mellitus, Type 2 , Humans , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/therapy , Obesity/metabolism , Weight Loss , Denervation
2.
World J Gastroenterol ; 28(40): 5784-5800, 2022 Oct 28.
Article in English | MEDLINE | ID: mdl-36353205

ABSTRACT

Hepatitis B virus (HBV) infection is a global public health issue. Interferon-α (IFN-α) treatment has been used to treat hepatitis B for over 20 years, but fewer than 5% of Asians receiving IFN-α treatment achieve functional cure. Thus, IFN-α retreatment has been introduced to enhance antiviral function. In recent years, immune-related studies have found that the complex interactions between immune cells and cytokines could modulate immune response networks, in-cluding both innate and adaptive immunity, triggering immune responses that control HBV replication. However, heterogeneity of the immune system to control HBV infection, particularly HBV-specific CD8+ T cell heterogeneity, has consequ-ential effects on T cell-based immunotherapy for treating HBV infection. Altogether, the host's genetic variants, negative-feedback regulators and HBV components affecting the immune system's ability to control HBV. In this study, we reviewed the literature on potential immune mechanisms affecting the immune control of HBV and the clinical effects of IFN-α treatment and retreatment.


Subject(s)
Hepatitis B, Chronic , Hepatitis B , Humans , Interferon-alpha/therapeutic use , Interferon-alpha/pharmacology , Hepatitis B virus , Hepatitis B Surface Antigens , Hepatitis B/drug therapy , Antiviral Agents/pharmacology , Retreatment , Virus Replication
3.
Transl Stroke Res ; 12(1): 136-146, 2021 02.
Article in English | MEDLINE | ID: mdl-32240524

ABSTRACT

Regulatory T cells (Tregs) play an immunosuppressive role in various diseases, yet their function remains controversial in stroke and obscure in diabetic stroke. In the present study, Tregs were found downregulated in the peripheral blood of type 2 diabetes mellitus (T2DM) stroke models and patients compared with controls. In ischemic stroke mice (both T2DM and wild type), endogenous Tregs boosted by CD28SA increased CD206+ M2 macrophage/microglia cells, decreased infarct volumes, and improved neurological recovery. Our results demonstrated the potential of boosting Tregs for treating T2DM stroke. Furthermore, we utilized an optical imaging probe (IRD-αCD206) to target M2 macrophage/microglia cells and demonstrated its effect in visualizing M2 macrophage/microglia cells in vivo in ischemic brain tissue.


Subject(s)
Diabetes Mellitus, Type 2/diagnostic imaging , Macrophages/physiology , Optical Imaging/methods , Phenotype , Stroke/diagnostic imaging , T-Lymphocytes, Regulatory/physiology , Animals , Brain Ischemia/diagnostic imaging , Brain Ischemia/immunology , Diabetes Mellitus, Type 2/immunology , Humans , Male , Mice , Mice, Inbred C57BL , Stroke/immunology
4.
Zhonghua Yi Xue Za Zhi ; 88(23): 1621-3, 2008 Jun 17.
Article in Chinese | MEDLINE | ID: mdl-19035102

ABSTRACT

OBJECTIVE: To investigate the characteristics of clinical manifestations, diagnostic imaging, pathology, and microsurgical treatment of spinal cavernous malformation. METHODS: The clinical data of 28 patients with spinal cavernous malformation undergoing total resection through posterior approach during 1991-2006, all receiving MRI examination and 22 also receiving spinal DSA examination, were analyzed. RESULTS: Among the 28 cases, 8 lesions were located in the cervical segment of the spinal cord; 12 lesions in the cervical-thoracic segment; 4 lesions in the thoracic segment; 2 in the lumbar segment, and 2 in the thoraco-lumbar segment. The MRI images looked like mulberry; a black ring around the cavernoma was indicated. The spinal cord tissues around the lesion were obviously stained by the deposited hemosiderin. Follow-up of 3 months to 6 year showed no recurrence. CONCLUSION: MRI is the most reliable method for diagnosis of spinal cavernous malformation and surgical resection is the best treatment method. The key of success is meticulous surgical techniques. DSA helps differentiate spinal cavernous malformation from other arterio-venous malformations.


Subject(s)
Central Nervous System Vascular Malformations/surgery , Microsurgery/methods , Spinal Cord/surgery , Adolescent , Adult , Arteriovenous Malformations/pathology , Central Nervous System Vascular Malformations/pathology , Cervical Vertebrae , Child , Diagnosis, Differential , Female , Follow-Up Studies , Humans , Magnetic Resonance Imaging/methods , Male , Middle Aged , Spinal Cord/blood supply , Spinal Cord/pathology , Thoracic Vertebrae , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...